Chronic rapamycin pretreatment modulates arginase/inducible nitric oxide synthase balance attenuating aging-dependent susceptibility to Trypanosoma cruzi infection and acute myocarditis.

Abstract

Considering the efficacy of rapamycin in increasing lifespan and healthspan, attenuating the aging-dependent immunological decline, we compared the evolution of Trypanosoma cruzi infection and acute myocarditis in young and elderly mice untreated and chronically treated with this drug. Five groups were investigated: young uninfected and infected, elderly uninfected and infected with Trypanosoma cruzi untreated and treated with rapamycin (4 mg/kg every 3 days) from the 8th to the 96th week of age. Seven days after the last treatment, elderly mice were inoculated with T. cruzi. Young animals were infected at 8-weeks-old. Untreated elderly mice exhibited increase parasitemia, parasite load and myocarditis, which were associated to down-regulation in IL-2, IL-6, IFN-γ, TNF, anti-T. cruzi immunoglobulin G (IgG) total, IgG1 and IgG2a plasma levels, inducible nitric oxide synthase (iNOS) gene expression and nitric oxide (NO) cardiac production, as well as upregulation in Arginase-1 gene expression and arginase activity compared to young animals. These parameters were improved in rapamycin-pretreated elderly mice, which exhibited a better parasitological control, reduced heart inflammation and microstructural damage. These responses were associated with a better balance between Th1 and Th2 effectors similar to that observed in young animals, including an improved activation of Th1 cytokines and the iNOS pathway that positively regulates NO biosynthesis, contradicting the predominant activation of the arginase pathway in untreated elderly animals. Thus, our findings suggest that chronic pretreatment with rapamycin can attenuate immunosenescence in mice, contributing to prolong parasite resistance and attenuate acute myocarditis in elderly host challenged by T. cruzi.

• Authors: Margarida Pereira-Santos, Elda Gonçalves-Santos, Matheus Augusto Souza, Ivo Santana Caldas, Graziela Domingues Almeida Lima, Reggiani Vilela Gonçalves, Rômulo Dias Novaes
• Journal: Experimental gerontology (Exp Gerontol) Vol. 159 Pg. 111676 (03 2022) ISSN: 1873-6815 [Electronic] England
• PMID: 34968674 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2021 Elsevier Inc. All rights reserved.

Chemical References

• Nitric Oxide
• Nitric Oxide Synthase Type II
• Arginase
• Sirolimus

Topics

• Aging
• Animals
• Arginase (metabolism)
• Chagas Disease (drug therapy)
• Mice
• Myocarditis (drug therapy, parasitology)
• Nitric Oxide (metabolism)
• Nitric Oxide Synthase Type II (metabolism)
• Sirolimus (pharmacology)
• Trypanosoma cruzi (metabolism)